459 related articles for article (PubMed ID: 26629548)
1. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
2. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
3. Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls.
Bernstein CN; Nayar G; Hamel A; Blanchard JF
J Clin Microbiol; 2003 Nov; 41(11):4986-90. PubMed ID: 14605128
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
[TBL] [Abstract][Full Text] [Related]
5. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis.
Stumme F; Steffens N; Steglich B; Mathies F; Nawrocki M; Sabihi M; Soukou-Wargalla S; Göke E; Kempski J; Fründt T; Weidemann S; Schramm C; Gagliani N; Huber S; Bedke T
Front Immunol; 2024; 15():1307297. PubMed ID: 38510236
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB
Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347
[TBL] [Abstract][Full Text] [Related]
7. Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis.
Bajraktari G; Elger T; Huss M; Loibl J; Albert A; Kandulski A; Müller M; Tews HC; Buechler C
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731984
[TBL] [Abstract][Full Text] [Related]
8. Association between inflammatory bowel disease and primary sclerosing cholangitis: Insights from bibliometric analysis.
Tang Q; Li L; Li Y; Yin W; Zhong X
Medicine (Baltimore); 2024 May; 103(21):e38257. PubMed ID: 38788011
[TBL] [Abstract][Full Text] [Related]
9. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.
Wittek A; Steglich B; Casar C; Seiz O; Huber P; Ehlken H; Reher D; Wende S; Bedke T; Kempski J; Böttcher M; Bang C; Thingholm L; Krech T; Lohse AW; Sauter G; Rösch T; Franke A; Schramm C; Gagliani N; Pelczar P; Huber S
Inflamm Bowel Dis; 2024 Jun; 30(6):900-910. PubMed ID: 37540889
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk.
Yuan F; Hung RJ; Walsh N; Zhang H; Platz EA; Wheeler W; Song L; Arslan AA; Beane Freeman LE; Bracci P; Canzian F; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Le Marchand L; Neale RE; Rosendahl J; Scelo G; Shu XO; Visvanathan K; White E; Zheng W; Albanes D; Amiano P; Andreotti G; Babic A; Bamlet WR; Berndt SI; Brennan P; Bueno-de-Mesquita B; Buring JE; Campbell PT; Chanock SJ; Fuchs CS; Gaziano JM; Goggins MG; Hackert T; Hartge P; Hassan MM; Holly EA; Hoover RN; Katzke V; Kirsten H; Kurtz RC; Lee IM; Malats N; Milne RL; Murphy N; Ng K; Oberg AL; Porta M; Rabe KG; Real FX; Rothman N; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Wang X; Wentzensen N; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Shi J; Duell EJ; Amundadottir LT; Li D; Petersen GM; Wolpin BM; Risch HA; Yu K; Klein AP; Stolzenberg-Solomon R
Cancer Res; 2020 Sep; 80(18):4004-4013. PubMed ID: 32641412
[TBL] [Abstract][Full Text] [Related]
11. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
Ricciuto A; Liu K; El-Matary W; Amin M; Amir AZ; Aumar M; Auth M; Di Guglielmo MD; Druve Tavares Fagundes E; Rodrigues Ferreira A; Furuya KN; Gupta N; Guthery S; Horslen SP; Jensen K; Kamath BM; Kerkar N; Koot BGP; Laborda TJ; Lee CK; Loomes KM; Mack C; Martinez M; Montano-Loza A; Ovchinsky N; Papadopoulou A; Perito ER; Sathya P; Schwarz KB; Shah U; Shteyer E; Soufi N; Stevens JP; Taylor A; Tessier ME; Valentino P; Woynarowski M; Deneau M;
Aliment Pharmacol Ther; 2024 May; 59(10):1236-1247. PubMed ID: 38462727
[TBL] [Abstract][Full Text] [Related]
12. Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis.
Elger T; Fererberger T; Huss M; Sommersberger S; Mester P; Stoeckert P; Gunawan S; Liebisch G; Loibl J; Kandulski A; Müller M; Buechler C; Tews HC
Exp Mol Pathol; 2024 Jun; 137():104900. PubMed ID: 38729058
[TBL] [Abstract][Full Text] [Related]
13. Protective function of sclerosing cholangitis on IBD.
Bedke T; Stumme F; Tomczak M; Steglich B; Jia R; Bohmann S; Wittek A; Kempski J; Göke E; Böttcher M; Reher D; Franke A; Lennartz M; Clauditz T; Sauter G; Fründt T; Weidemann S; Tiegs G; Schramm C; Gagliani N; Pelczar P; Huber S
Gut; 2024 Jun; ():. PubMed ID: 38839272
[TBL] [Abstract][Full Text] [Related]
14. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
Torres J; Caprioli F; Katsanos KH; Lobatón T; Micic D; Zerôncio M; Van Assche G; Lee JC; Lindsay JO; Rubin DT; Panaccione R; Colombel JF
J Crohns Colitis; 2016 Dec; 10(12):1385-1394. PubMed ID: 27282402
[TBL] [Abstract][Full Text] [Related]
15. Role of the microbiota and antibiotics in primary sclerosing cholangitis.
Tabibian JH; Talwalkar JA; Lindor KD
Biomed Res Int; 2013; 2013():389537. PubMed ID: 24232746
[TBL] [Abstract][Full Text] [Related]
16. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.
Shaw DG; Aguirre-Gamboa R; Vieira MC; Gona S; DiNardi N; Wang A; Dumaine A; Gelderloos-Arends J; Earley ZM; Meckel KR; Ciszewski C; Castillo A; Monroe K; Torres J; Shah SC; Colombel JF; Itzkowitz S; Newberry R; Cohen RD; Rubin DT; Quince C; Cobey S; Jonkers IH; Weber CR; Pekow J; Wilson PC; Barreiro LB; Jabri B
Nat Med; 2023 Jun; 29(6):1520-1529. PubMed ID: 37322120
[TBL] [Abstract][Full Text] [Related]
17. Type II diabetes mellitus increases the risk of inflammatory bowel disease in a prospective cohort study.
Li L; Zhuang Y; Ran Y; Xu Y; Wang L; Chen L; Chen J; Sun Y; Mei L; Ye F; Dai F
Clin Nutr ESPEN; 2024 Jun; 61():212-218. PubMed ID: 38777435
[TBL] [Abstract][Full Text] [Related]
18. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.
Lakatos PL; Lakatos L
World J Gastroenterol; 2008 Jul; 14(25):3937-47. PubMed ID: 18609676
[TBL] [Abstract][Full Text] [Related]
19. Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.
Tabibian JH; O'Hara SP; Lindor KD
Scand J Gastroenterol; 2014 Aug; 49(8):901-8. PubMed ID: 24990660
[TBL] [Abstract][Full Text] [Related]
20. Letter to editor: effects of vancomycin in primary sclerosing cholangitis with and without inflammatory bowel disease.
Malik S; Loganathan P; Mohan BP
Scand J Gastroenterol; 2024 May; 59(5):630. PubMed ID: 38289040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
